$120.80
-22.86 (-15.91%)
Performance
1D
—
1W
-15.78%
1M
-9.10%
3M
+61.41%
6M
+97.19%
1Y
+50.89%
YTD
+35.93%
Open$126.68
Previous Close$143.66
Day High$130.00
Day Low$117.21
52W High$166.48
52W Low$41.50
Volume—
Avg Volume919.1K
Market Cap6.41B
P/E Ratio—
EPS$-9.75
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$115.55
Above
SMA 200
$78.67
Above
RSI (14)
53.9
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
17 analysts
Price Target
-72.2% upside
Current
$120.80
$120.80
Target
$33.59
$33.59
$28.45
$33.59 avg
$56.21
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 166.58M | 120.39M | 2.02B |
| Net Income | -462,202,391 | -300,630,304 | 154.03M |
| Profit Margin | -277.5% | -263.6% | 7.6% |
| EBITDA | -473,039,322 | -324,772,245 | 214.07M |
| Free Cash Flow | — | — | 137.52M |
| Rev Growth | +38.4% | +38.4% | +15.5% |
| Debt/Equity | — | — | 0.96 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $288.24 | -2.24% | 81.4 | 513.86B |
| AMGN | Amgen Inc | $460.28 | -3.80% | 28.5 | 249.09B |
| GILD | Gilead Sciences Inc | $167.57 | -3.96% | — | 212.04B |
| VRTX | Vertex Pharmaceuticals Inc | $542.50 | -1.19% | 30.6 | 134.77B |
| REGN | Regeneron Pharmaceuticals | $902.90 | -2.98% | 19.5 | 84.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.66 | -2.74% | 28.8 | 23.28B |